EVOLVE study

In This Section

The Evolve study: Evaluating the Impact of a Digital Youth Mental Health Service

Investigator: Prof Mario Alvarez-Jimenez

Many young people struggle with feelings of depression and anxiety. The Evolve study will help us to understand whether a digital mental health platform designed especially for young people might be able to help.

The Evolve Study is a ‘randomised controlled trial’ (RCT). This means people are allocated to groups and each group receives a different treatment. To try to make sure the groups are the same, each participant is put into a group by chance (random). The results are compared to see if there is a difference between the groups.

There are two groups in the Evolve study. One group will use the Moderated Online Social Therapy (MOST) platform. The other group will not use MOST.

What does the study involve?

Participants are invited to take part in a 45-minute online surveys, six times over 12 months. Those in the MOST group will have access during the 12 months.

Reimbursement

Survey participants will be reimbursed AUD $50 per survey ($300 total).

Eligibility

Participants must be aged 12–25 with self-reported symptoms of depression and/or anxiety.

Recruitment

Participation in the study is completely voluntary and researchers will ensure participants have all information about the study before they provide consent.

To take part, click HERE.

This work is funded by the National Health and Medical Research Council. Orygen works with the Centre for Youth Mental Health at the University of Melbourne to deliver research and innovative mental health care for young people.